Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Current Assets (2023 - 2026)

Camp4 Therapeutics' Current Assets history spans 3 years, with the latest figure at $114.1 million for Q4 2025.

  • On a quarterly basis, Current Assets rose 71.87% to $114.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $114.1 million, a 71.87% increase, with the full-year FY2025 number at $114.1 million, up 71.87% from a year prior.
  • Current Assets hit $114.1 million in Q4 2025 for Camp4 Therapeutics, up from $77.7 million in the prior quarter.
  • Over the last five years, Current Assets for CAMP hit a ceiling of $114.1 million in Q4 2025 and a floor of $5.5 million in Q3 2024.
  • Historically, Current Assets has averaged $56.6 million across 3 years, with a median of $51.7 million in 2025.
  • Biggest five-year swings in Current Assets: surged 65.9% in 2024 and later soared 1311.85% in 2025.
  • Tracing CAMP's Current Assets over 3 years: stood at $40.0 million in 2023, then surged by 65.9% to $66.4 million in 2024, then surged by 71.87% to $114.1 million in 2025.
  • Business Quant data shows Current Assets for CAMP at $114.1 million in Q4 2025, $77.7 million in Q3 2025, and $41.1 million in Q2 2025.